Tinupri, Almae, Jane V.

HRN: 18-78-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2023
CEFUROXIME 750MG (VIAL)
10/29/2023
11/04/2023
IVT
630mg
Q8
Pneumonia, UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: